Mesoblast Limited (MESO) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear

Mesoblast Limited

NASDAQ: MESO · Real-Time Price · USD
13.83
-2.12 (-13.29%)
At close: Aug 29, 2025, 3:59 PM
13.82
-0.07%
After-hours: Aug 29, 2025, 06:01 PM EDT

Mesoblast Income Statement

Financials in USD. Fiscal year is July - June.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020
Revenue
1.58M 1.58M 1.26M 1.26M 1.69M 1.69M 2.14M 1.94M 1.98M 1.44M 2.22M 2.01M 2.38M 3.59M 2M 1.91M 2.24M 1.29M
Cost of Revenue
3.28M 3.28M 10.84M 10.84M 9.7M 9.7M 15.42M 13.31M 15.58M 10.61M 16.08M 13.84M 16.79M 16.86M 14.07M 19.77M 20.69M 28.37M
Gross Profit
-1.7M -1.7M -9.58M -9.58M -8M -8M -13.28M -11.37M -13.6M -9.17M -13.86M -11.83M -14.41M -13.27M -12.07M -17.86M -18.45M -27.08M
Operating Income
-20.62M -20.62M -22.01M -22.01M -20.07M -20.07M -19.08M -14.46M -21.11M -16M -19.81M -19.34M -22.22M -19.21M -19.3M -25.91M -26.31M -35.56M
Interest Income
n/a n/a n/a n/a n/a n/a 4.26M n/a 154K 60K 2K 387K 1K n/a 4.05M 2K 5K 16K
Pretax Income
-23.86M -23.86M -27.75M -27.75M -16.32M -16.32M -21.96M -18.65M -24.56M -16.94M -21.51M -21.35M -26.02M -22.71M -22.13M -26.61M -25.62M -25.27M
Net Income
-23.97M -23.97M -27.71M -27.71M -16.27M -16.27M -21.92M -18.6M -24.49M -16.88M -21.45M -21.3M -25.95M -22.64M -22.06M -26.52M -25.69M -24.54M
Selling & General & Admin
8.59M 8.59M 6.07M 6.07M 5.74M 5.74M 14.41M 12.65M 14.28M 11.76M 16.99M 13.16M 14.4M 13.41M 14.25M 15.42M 14.32M 19.6M
Research & Development
10.32M 10.32M 6.35M 6.35M 6.32M 6.32M 6.69M 7.07M 7.68M 5.74M 5.04M 8.25M 10.2M 9.33M 7.05M 12.44M 14.24M 19.28M
Other Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 11.04M 5.53M 6.59M 7.71M 7M n/a n/a n/a
Operating Expenses
18.92M 18.92M 12.43M 12.43M 12.06M 12.06M 20.88M 16.4M 21.96M 17.51M 22.03M 21.35M 24.6M 22.92M 21.29M 27.82M 28.55M 38.87M
Interest Expense
n/a n/a n/a n/a n/a n/a 3.77M 4.98M 4.9M 4.55M 4.41M 4.3M 4.06M 4.14M n/a 3.95M 3.99M 3.93M
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a 8.73M 6.25M 7.89M 4.87M 11.04M 5.59M 6.59M 7.54M 7.01M 7.33M 6.45M 11.92M
Cost & Expenses
22.2M 22.2M 23.26M 23.26M 21.76M 21.76M 20.88M 16.4M 21.96M 17.51M 22.03M 21.35M 24.6M 22.92M 21.29M 27.82M 28.55M 38.87M
Income Tax Expense
106K 106K 44.5K 44.5K 51K 51K -40K -46K -71K -55K -52K -45K -80K -62K -65K -98K 74K -730K
Shares Outstanding (Basic)
114.13M 114.13M 112.2M 112.2M 85.15M 85.15M 94.02M 73.52M 77.05M 69.48M 64.99M 64.95M 64.81M 64.81M 64.73M 60.4M 58.64M 58.25M
Shares Outstanding (Diluted)
114.23M 114.23M 112.19M 112.19M 85.15M 85.15M 94.19M 73.66M 77.05M 69.61M 64.99M 64.96M 64.81M 64.8M 64.73M 60.44M 58.64M 58.25M
EPS (Basic)
-0.21 -0.21 -0.25 -0.25 -0.19 -0.19 -0.23 -0.25 -0.32 -0.24 -0.33 -0.33 -0.4 -0.35 -0.34 -0.44 -0.44 -0.42
EPS (Diluted)
-0.21 -0.21 -0.25 -0.25 -0.19 -0.19 -0.23 -0.25 -0.32 -0.24 -0.33 -0.33 -0.4 -0.35 -0.34 -0.44 -0.44 -0.42
EBITDA
-9.45M -9.45M -15.26M -15.26M -12.78M -12.78M -17.66M -13.47M -19.19M -14.9M -18.66M -18.23M -20.86M -17.47M -18.17M -24.82M -21.62M -37.56M
EBIT
-9.99M -9.99M -15.69M -15.69M -13.29M -13.29M -18.18M -13.66M -19.65M -12.39M -17.1M -17.44M -21.96M -18.57M -18.06M -22.66M -21.62M -22.37M
Depreciation & Amortization
537.5K 537.5K 436K 436K 511.5K 511.5K 927K 990K 1.08M 1.1M 1.07M 1.11M 1.1M 1.09M 1.13M 1.08M 1.05M 1M